PRA8 COSTS AND BENEFITS ASSOCIATED WITH INITIATION OF FLUTICASONE VERSUS MONTELUKAST AS CONTROLLER THERAPY IN A MEDICAID ASTHMATIC POPULATION
R Balkrishnan, F Camacho, MS Schechter, RA Pleasants, DL BowtonVolume:
5
Year:
2002
Language:
english
DOI:
10.1016/s1098-3015(10)60982-5
File:
PDF, 62 KB
english, 2002